TRPC1 and cancer: In addition, we found that ODC suicide inhibitor DFMO inhibits expression of TRPC1 and STIM1 in CRC cells, thus, reversing Ca2+ channel remodeling in CRC and providing a mechanism for cancer chemoprevention by polyamine synthesis inhibition.